Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Immunosuppressive Agents"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 48731
Tytuł:
Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis.
Autorzy:
Zhang Y; Department of Hematology, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China.
Li J; Department of Oncology and Hematology, Liuyang Hospital of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410300, Hunan, China.
Li X; Department of Nephrology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China.
Geng Q; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China.
Xie Y; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China.
Zhang G; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China.
Wei M; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China. .
Ma Y; Department of Hematology, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China. .
Pokaż więcej
Źródło:
Systematic reviews [Syst Rev] 2024 Apr 04; Vol. 13 (1), pp. 101. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Immunosuppressive Agents*/therapeutic use
Anemia, Aplastic*/drug therapy
Anemia, Aplastic*/epidemiology
Hydrazines*
Pyrazoles*
Humans ; Immunosuppression Therapy ; Benzoates/therapeutic use ; Pathologic Complete Response ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Satisfaction and effectiveness of switching from intravenous to subcutaneous belimumab treatment in daily clinical practice.
Autorzy:
Frade-Sosa B; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Salman-Monte TC; Rheumatology Department, Hospital Del Mar/Parc de Salut Mar-IMIM, Barcelona, Spain.
Narváez J; Rheumatology Department, Hospital de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
Peralta I; Rheumatology Department, Hospital Universitario Germans Trias I Pujol, Badalona, Spain.
Sandoval S; Rheumatology Department, Hospital Vall D'Hebron, Barcelona, Spain.
Magallares B; Rheumatology Department, Hospital Santa Creu I Sant Pau, Barcelona, Spain.
Heredia S; Rheumatology Department, Hospital Moisès Broggi, Barcelona, Spain.
Sapena N; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Riveros-Frutos A; Rheumatology Department, Hospital Universitario Germans Trias I Pujol, Badalona, Spain.
Olivé A; Rheumatology Department, Hospital Universitario Germans Trias I Pujol, Badalona, Spain.
Corominas H; Rheumatology Department, Hospital Santa Creu I Sant Pau, Barcelona, Spain.
Cortés-Hernández J; Rheumatology Department, Hospital Vall D'Hebron, Barcelona, Spain.
Gómez-Puerta JA; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Faculty of Medicine, University of Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (5), pp. 481-489. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Observational Study; Multicenter Study; Journal Article
MeSH Terms:
Immunosuppressive Agents*/therapeutic use
Lupus Erythematosus, Systemic*/drug therapy
Antibodies, Monoclonal, Humanized*
Humans ; Treatment Outcome ; Personal Satisfaction
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Infliximab in neurosarcoidosis: a systematic review and meta-analysis.
Autorzy:
Chaiyanarm S; Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Satiraphan P; Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Apiraksattaykul N; Siriraj Neuroimmunology Center, Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Jitprapaikulsan J; Siriraj Neuroimmunology Center, Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.; Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Owattanapanich W; Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Rungjirajittranon T; Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Nanthasi W; Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Feb; Vol. 11 (2), pp. 466-476. Date of Electronic Publication: 2023 Dec 12.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Immunosuppressive Agents*/therapeutic use
Adrenal Cortex Hormones*
Central Nervous System Diseases*
Sarcoidosis*
Humans ; Infliximab/adverse effects ; Recurrence
SCR Disease Name:
Neurosarcoidosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effectiveness and safety of immunosuppressive regimens used as maintenance therapy in kidney transplantation: The CESIT study.
Autorzy:
Bellini A; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.; Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Finocchietti M; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.
Rosa AC; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.
Nordio M; Azienda Zero of the Veneto Region, Padua, Italy.
Ferroni E; Azienda Zero of the Veneto Region, Padua, Italy.
Massari M; National Centre for Drug Research and Evaluation, Istituto Superiore Di Sanità, Rome, Italy.
Spila Alegiani S; National Centre for Drug Research and Evaluation, Istituto Superiore Di Sanità, Rome, Italy.
Masiero L; Italian National Transplant Centre, Istituto Superiore di Sanità, Rome, Italy.
Bedeschi G; Italian National Transplant Centre, Istituto Superiore di Sanità, Rome, Italy.
Cardillo M; Italian National Transplant Centre, Istituto Superiore di Sanità, Rome, Italy.
Lucenteforte E; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Piccolo G; Regional Transplant Coordination, Lombardy Region, Milan, Italy.
Leoni O; Department of Health of Lombardy Region, Epidemiology Observatory, Milan, Italy.
Pierobon S; Azienda Zero of the Veneto Region, Padua, Italy.
Ledda S; General Directorate for Health, Sardinia Region, Italy.
Garau D; General Directorate for Health, Sardinia Region, Italy.
Davoli M; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.
Addis A; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.
Belleudi V; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.
Pokaż więcej
Corporate Authors:
CESIT study group
Źródło:
PloS one [PLoS One] 2024 Jan 02; Vol. 19 (1), pp. e0295205. Date of Electronic Publication: 2024 Jan 02 (Print Publication: 2024).
Typ publikacji:
Multicenter Study; Observational Study; Journal Article
MeSH Terms:
Immunosuppressive Agents*/adverse effects
Kidney Transplantation*
Humans ; Cyclosporine/adverse effects ; Diabetes Mellitus/epidemiology ; Drug Therapy, Combination ; Mycophenolic Acid/adverse effects ; Tacrolimus/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Emerging therapies and respiratory infections: Focus on the impact of immunosuppressants and immunotherapies.
Autorzy:
Patterson CM; Consultant in Respiratory Transplant Medicine, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK. Electronic address: .
Shaw TD; Academic Clinical Lecturer in Infectious Diseases and Medical Microbiology, Wellcome-Wolfson Institute for Experimental Medicine, Queen's University, Belfast, UK.
Gerovasili V; Consultant in Respiratory Transplant Medicine, Royal Brompton and Harefield hospital, part of Guys and St Thomas NHS Foundation trust, London, UK.
Khatana U; Specialty Trainee in Respiratory Medicine, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
Jose RJ; Consultant in Host Defence, Royal Brompton and Harefield hospital, part of Guys and St Thomas NHS Foundation trust, London, UK.
Pokaż więcej
Źródło:
Clinical medicine (London, England) [Clin Med (Lond)] 2024 Jan; Vol. 24 (1), pp. 100015. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunosuppressive Agents*/therapeutic use
Respiratory Tract Infections*/drug therapy
Humans ; Immunotherapy ; Adaptive Immunity ; Immunocompromised Host
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Helios as a Potential Biomarker in Systemic Lupus Erythematosus and New Therapies Based on Immunosuppressive Cells.
Autorzy:
París-Muñoz A; Department of Immunology and Oncology and NanoBiomedicine Initiative, Centro Nacional de Biotecnología (CNB-CSIC), 28049 Madrid, Spain.; Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, IdiPAZ, Hospital Universitario La Paz, 28049 Madrid, Spain.; IdiPAZ-CNIO Pediatric Onco-Hematology Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), 28049 Madrid, Spain.
León-Triana O; Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, IdiPAZ, Hospital Universitario La Paz, 28049 Madrid, Spain.; IdiPAZ-CNIO Pediatric Onco-Hematology Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), 28049 Madrid, Spain.
Pérez-Martínez A; Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, IdiPAZ, Hospital Universitario La Paz, 28049 Madrid, Spain.; IdiPAZ-CNIO Pediatric Onco-Hematology Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), 28049 Madrid, Spain.
Barber DF; Department of Immunology and Oncology and NanoBiomedicine Initiative, Centro Nacional de Biotecnología (CNB-CSIC), 28049 Madrid, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 29; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 29.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunosuppressive Agents*
Lupus Erythematosus, Systemic*/drug therapy
Animals ; Mice ; Humans ; Biomarkers ; Disease Models, Animal ; Disease Progression ; Homeostasis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Research progress of ophthalmic preparations of immunosuppressants.
Autorzy:
Liu Y; School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China.
Xu H; School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China.
Yan N; Department of Pharmacy, Jin Hua Municipal Maternal and Child Health Care Hospital, Jinhua, Zhejiang, 321000, China.
Tang Z; School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China.; Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China.
Wang Q; School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China.; Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China.
Pokaż więcej
Źródło:
Drug delivery [Drug Deliv] 2023 Dec; Vol. 30 (1), pp. 2175925.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Eye Diseases*/drug therapy
Immunosuppressive Agents*/pharmacology
Humans ; Administration, Ophthalmic ; Drug Delivery Systems/methods ; Eye ; Liposomes/pharmacology ; Ophthalmic Solutions/chemistry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Phenotype and disease course differences in monogenic and sporadic childhood lupus.
Autorzy:
Al-Mayouf SM; Pediatric Rheumatology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Alkhars F; Pediatric Rheumatology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
AlSaleem A; Pediatric Rheumatology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Pokaż więcej
Źródło:
Lupus [Lupus] 2023 Nov; Vol. 32 (13), pp. 1548-1554. Date of Electronic Publication: 2023 Oct 25.
Typ publikacji:
Journal Article
MeSH Terms:
Immunosuppressive Agents*/therapeutic use
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Systemic*/genetics
Humans ; Child ; Retrospective Studies ; Cross-Sectional Studies ; Rituximab ; Disease Progression ; Severity of Illness Index
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Post-transplant diarrhea and immunosuppressant withdrawal: Insights and limitations.
Autorzy:
Kulkarni M; Department of Nephrology, Father Muller Medical College, Mangalore, Karnataka, India.
Pokaż więcej
Źródło:
Journal of postgraduate medicine [J Postgrad Med] 2023 Oct-Dec; Vol. 69 (4), pp. 192-193.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Immunosuppressive Agents*/adverse effects
Kidney Transplantation*
Humans ; Diarrhea/etiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Model based assessment of food and acid reducing agent effects on oral absorption of mezigdomide (CC-92480), a novel cereblon E3 ligase modulator.
Autorzy:
Wu F; Bristol Myers Squibb, Princeton, New Jersey, USA.
Liu L; Bristol Myers Squibb, Princeton, New Jersey, USA.
Gaudy A; Bristol Myers Squibb, Princeton, New Jersey, USA.
Wang X; Bristol Myers Squibb, Princeton, New Jersey, USA.
Carayannopoulos L; Bristol Myers Squibb, Princeton, New Jersey, USA.
Pourdehnad M; Bristol Myers Squibb, Princeton, New Jersey, USA.
Lamba M; Bristol Myers Squibb, Princeton, New Jersey, USA.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Oct; Vol. 12 (10), pp. 1473-1484. Date of Electronic Publication: 2023 Sep 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Reducing Agents*
Immunosuppressive Agents*
Humans ; Administration, Oral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Deceased donor kidney transplanted in childhood functioning well after 52 years.
Autorzy:
Spartà G; Pediatric Nephrology Unit, University Children's Hospital, Zurich, Switzerland.
Hadaya K; Service of Nephrology and Hypertension, Geneva University Hospitals, Clinique Des Grangettes-Hirslanden, Geneva, Switzerland.
Paunier L; Pediatric Nephrology Unit, Department of Pediatrics, Geneva University Hospital, Geneva, Switzerland.
Girardin E; Pediatric Nephrology Unit, Department of Pediatrics, Geneva University Hospital, Geneva, Switzerland.
Leumann E; Pediatric Nephrology Unit, University Children's Hospital, Zurich, Switzerland. .
Pokaż więcej
Źródło:
Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2023 Oct; Vol. 38 (10), pp. 3489-3492. Date of Electronic Publication: 2023 Mar 16.
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunosuppressive Agents*/adverse effects
Azathioprine*/therapeutic use
Male ; Child ; Humans ; Middle Aged ; Adolescent ; Graft Survival ; Tissue Donors ; Kidney ; Graft Rejection
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
High-volume hybridoma sequencing on the NeuroMabSeq platform enables efficient generation of recombinant monoclonal antibodies and scFvs for neuroscience research.
Autorzy:
Mitchell KG; Department of Physiology and Membrane Biology, University of California Davis School of Medicine, Davis, Davis, CA, USA.; Bioinformatics Core, Genome Center, University of California Davis, Davis, CA, USA.
Gong B; Department of Physiology and Membrane Biology, University of California Davis School of Medicine, Davis, Davis, CA, USA.
Hunter SS; Bioinformatics Core, Genome Center, University of California Davis, Davis, CA, USA.
Burkart-Waco D; DNA Technology Core, Genome Center, University of California Davis, Davis, CA, USA.
Gavira-O'Neill CE; Department of Physiology and Membrane Biology, University of California Davis School of Medicine, Davis, Davis, CA, USA.
Templeton KM; Department of Physiology and Membrane Biology, University of California Davis School of Medicine, Davis, Davis, CA, USA.
Goethel ME; Department of Physiology and Membrane Biology, University of California Davis School of Medicine, Davis, Davis, CA, USA.
Bzymek M; Department of Physiology and Membrane Biology, University of California Davis School of Medicine, Davis, Davis, CA, USA.
MacNiven LM; Department of Physiology and Membrane Biology, University of California Davis School of Medicine, Davis, Davis, CA, USA.
Murray KD; Department of Physiology and Membrane Biology, University of California Davis School of Medicine, Davis, Davis, CA, USA.; Department of Psychiatry and Behavioral Sciences, University of California Davis School of Medicine, Davis, Davis, CA, USA.
Settles ML; Bioinformatics Core, Genome Center, University of California Davis, Davis, CA, USA.
Froenicke L; DNA Technology Core, Genome Center, University of California Davis, Davis, CA, USA.
Trimmer JS; Department of Physiology and Membrane Biology, University of California Davis School of Medicine, Davis, Davis, CA, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 27; Vol. 13 (1), pp. 16200. Date of Electronic Publication: 2023 Sep 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Antibodies, Monoclonal*/genetics
Immunosuppressive Agents*
Animals ; Mice ; Hybridomas ; Reproducibility of Results ; Databases, Nucleic Acid
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Multidrug resistant 1 (MDR1) C3435T and G2677T gene polymorphism: impact on the risk of acute rejection in pediatric kidney transplant recipients.
Autorzy:
Korkor MS; Pediatric Nephrology Unit, Mansoura University Children's Hospital, Faculty of Medicine, Mansoura University, Mansoura, Egypt. .
El-Desoky T; Pediatric respiratory and allergy Unit, Faculty of Medicine, Mansoura University Children's Hospital, Mansoura University, Mansoura, Egypt.
Mosaad YM; Clinical Immunology Unit, clinical pathology department and Mansoura Research center for cord stem cells (MARC_CSC), Faculty of medicine, Mansura University, Mansoura, Egypt.
Salah DM; Pediatric Department, Pediatric Nephrology Unit & Kidney Transplantation Unit, Cairo University Children Hospital, Kasr Al-Ainy Faculty of Medicine, Cairo University , Cairo, Egypt.
Hammad A; Pediatric Nephrology Unit, Mansoura University Children's Hospital, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Pokaż więcej
Źródło:
Italian journal of pediatrics [Ital J Pediatr] 2023 May 18; Vol. 49 (1), pp. 57. Date of Electronic Publication: 2023 May 18.
Typ publikacji:
Journal Article
MeSH Terms:
Kidney Transplantation*
Graft Rejection*/genetics
Graft Rejection*/prevention & control
ATP Binding Cassette Transporter, Subfamily B*/genetics
Tacrolimus*/administration & dosage
Tacrolimus*/pharmacokinetics
Immunosuppressive Agents*/administration & dosage
Immunosuppressive Agents*/pharmacokinetics
Pharmacogenomic Variants*
Humans ; Polymorphism, Single Nucleotide ; Pharmacogenetics ; Male ; Female ; Child, Preschool ; Child ; Adolescent ; Young Adult ; Risk
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
COVID-19 Disease in Pediatric Solid Organ Transplantation from Alpha to Omicron: A High Monocyte Count in the Preceding Three Months Portends a Risk for Severe Disease.
Autorzy:
Sirgi Y; Department of Surgery, Georgetown University Medical School, Washington, DC 20007, USA.
Stanojevic M; Department of Pediatrics, MedStar Georgetown University Hospital, Washington, DC 20007, USA.
Ahn J; Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC 20007, USA.
Yazigi N; MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC 20007, USA.
Kaufman S; MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC 20007, USA.
Khan K; MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC 20007, USA.
Vitola B; MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC 20007, USA.
Matsumoto C; MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC 20007, USA.
Kroemer A; MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC 20007, USA.
Fishbein T; MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC 20007, USA.
Ekong UD; MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC 20007, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jul 16; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 16.
Typ publikacji:
Journal Article
MeSH Terms:
Organ Transplantation*
COVID-19*/diagnosis
COVID-19*/epidemiology
Immunosuppressive Agents*/therapeutic use
Steroids*/therapeutic use
Humans ; Child ; Patient Acuity ; Male ; Female ; Child, Preschool ; Lymphocyte Count ; Monocytes/cytology ; Graft Rejection
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Application of a Fully Automated Dried Blood Spot Method for Therapeutic Drug Monitoring of Immunosuppressants: Another Step Toward Implementation of Dried Blood Spot Analysis.
Autorzy:
Deprez S; From the Laboratory of Toxicology, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
Stove C; From the Laboratory of Toxicology, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2023 Jul 01; Vol. 147 (7), pp. 786-796.
Typ publikacji:
Journal Article
MeSH Terms:
Immunosuppressive Agents*/therapeutic use
Tacrolimus*
Humans ; Dried Blood Spot Testing/methods ; Drug Monitoring/methods ; Cyclosporine
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The Effect of Calcineurin Inhibitors on MMPs Activity in Heart and Their Side Effects-A Review of Literature.
Autorzy:
Surówka A; Department of Plastic, Endocrine and General Surgery, Pomeranian Medical University, 72-010 Szczecin, Poland.
Prowans P; Department of Plastic, Endocrine and General Surgery, Pomeranian Medical University, 72-010 Szczecin, Poland.
Żołnierczuk M; Department of Plastic, Endocrine and General Surgery, Pomeranian Medical University, 72-010 Szczecin, Poland.
Miśkiewicz M; Department of Plastic, Endocrine and General Surgery, Pomeranian Medical University, 72-010 Szczecin, Poland.
Wawrowski T; Department of Plastic, Endocrine and General Surgery, Pomeranian Medical University, 72-010 Szczecin, Poland.
Skodda M; Department of Plastic, Endocrine and General Surgery, Pomeranian Medical University, 72-010 Szczecin, Poland.
Markowska M; Department of Plastic, Endocrine and General Surgery, Pomeranian Medical University, 72-010 Szczecin, Poland.; Department of Plastic and Reconstructive Surgery, 109 Military Hospital, 70-111 Szczecin, Poland.
Kędzierska-Kapuza K; Department of Gastroenterological Surgery and Transplantology, National Medical Institute of the Ministry of Interior Affairs and Administration, 02-507 Warsaw, Poland.; Department of Gastroenterological Surgery and Transplantology, Centre of Postgraduate, Medical Education in Warsaw, 02-507 Warsaw, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 18; Vol. 24 (12). Date of Electronic Publication: 2023 Jun 18.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Calcineurin Inhibitors*/adverse effects
Immunosuppressive Agents*/adverse effects
Cyclosporine/adverse effects ; Tacrolimus/adverse effects ; Matrix Metalloproteinases ; Calcineurin
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Real-world treatment patterns of immunosuppressants in Adults with systemic lupus erythematosus: A claims database analysis in the United States.
Autorzy:
Birt J; Eli Lilly & Co, Indianapolis, IN, USA.
Delbecque L; Eli Lilly & Co, Indianapolis, IN, USA.
O'brien D; Allscripts Healthcare Solutions Inc, Raleigh, NC, USA.
Wu J; Eli Lilly & Co, Indianapolis, IN, USA.
Vasey J; Allscripts Healthcare Solutions Inc, Raleigh, NC, USA.
Dean A; Allscripts Healthcare Solutions Inc, Raleigh, NC, USA.
Sudaria T; Allscripts Healthcare Solutions Inc, Raleigh, NC, USA.
Vadhariya A; Eli Lilly & Co, Indianapolis, IN, USA.
Pokaż więcej
Źródło:
Lupus [Lupus] 2023 Jun; Vol. 32 (7), pp. 815-826. Date of Electronic Publication: 2023 May 30.
Typ publikacji:
Journal Article
MeSH Terms:
Immunosuppressive Agents*/therapeutic use
Lupus Erythematosus, Systemic*/drug therapy
Humans ; Adult ; United States ; Azathioprine/therapeutic use ; Methotrexate/therapeutic use ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Developing a mechanistic understanding of the nonlinear pharmacokinetics of letermovir and prospective drug interaction with everolimus using physiological-based pharmacokinetic modeling.
Autorzy:
Menzel K; Merck & Co., Inc., Kenilworth, New Jersey, USA.
Kuo Y; Merck & Co., Inc., Kenilworth, New Jersey, USA.
Chen D; Kymera Therapeutics, Watertown, Massachusetts, USA.
Hartmann G; Simulations Plus, Lancaster, California, USA.
Wang YH; FDA, Silver Spring, Maryland, USA.
Cho CR; Merck & Co., Inc., Kenilworth, New Jersey, USA.
McCrea JB; Merck & Co., Inc., Kenilworth, New Jersey, USA.
Asari K; MSD K.K., Tokyo, Japan.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2023 Jun; Vol. 16 (6), pp. 1039-1048. Date of Electronic Publication: 2023 Apr 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Everolimus*/adverse effects
Immunosuppressive Agents*/pharmacokinetics
Humans ; Drug Interactions ; Acetates ; Cytochrome P-450 CYP3A/metabolism ; Models, Biological
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Oral antibiotics lower mycophenolate mofetil drug exposure, possibly by interfering with the enterohepatic recirculation: A case series.
Autorzy:
Simoons M; Department of Hospital Pharmacy, ErasmusMC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Naipal KAT; Department of Internal Medicine, ErasmusMC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
de Jong H; Department of Pediatrics, ErasmusMC, Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.; The ErasmusMC Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
den Hoed CM; The ErasmusMC Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Gastroenterology and Hepatology, ErasmusMC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
de Winter BCM; Department of Hospital Pharmacy, ErasmusMC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; The ErasmusMC Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Mulder MB; Department of Hospital Pharmacy, ErasmusMC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; The ErasmusMC Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Jun; Vol. 11 (3), pp. e01103.
Typ publikacji:
Journal Article
MeSH Terms:
Mycophenolic Acid*
Immunosuppressive Agents*
Humans ; Anti-Bacterial Agents ; Transplant Recipients
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Preventative effect of TSPO ligands on mixed antibody-mediated rejection through a Mitochondria-mediated metabolic disorder.
Autorzy:
Zhang Y; Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
He J; Department of Urology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Yang Z; Department of Urology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
Zheng H; Division of kidney Transplantation, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 2nd road Zhongshan, Yuexiu District, Guangzhou, 510080, China.
Deng H; Division of kidney Transplantation, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 2nd road Zhongshan, Yuexiu District, Guangzhou, 510080, China.
Luo Z; Division of kidney Transplantation, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 2nd road Zhongshan, Yuexiu District, Guangzhou, 510080, China.
Sun Q; Division of kidney Transplantation, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 2nd road Zhongshan, Yuexiu District, Guangzhou, 510080, China.
Sun Q; Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. .; Division of kidney Transplantation, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 2nd road Zhongshan, Yuexiu District, Guangzhou, 510080, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2023 May 02; Vol. 21 (1), pp. 295. Date of Electronic Publication: 2023 May 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunosuppressive Agents*/therapeutic use
T-Lymphocytes*
Animals ; Rats ; Carrier Proteins ; Immunoglobulin G ; Ligands ; Receptors, GABA-A ; Transplantation, Homologous
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 48731

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies